{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-077791","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2024-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.000608+00:00","generated_at":"2026-05-31T23:28:02.516273+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"iBio enters ATM equity facility for up to $7.35M in common stock sales","bullets":["Entry into ATM Agreement with Chardan Capital Markets and Craig-Hallum Capital Group for at-the-market offerings.","Aggregate market value of shares eligible for sale under the ATM prospectus supplement is $7,350,000.","Sales agents receive fixed commission rate of up to 3.0% of gross proceeds.","Shelf registration statement on Form S-3 filed on July 3, 2024, must be effective before sales can occur.","Company has no obligation to sell shares and may suspend offerings at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-077791","json":"https://secwatch.observer/filing/0001104659-24-077791.json","markdown":"https://secwatch.observer/filing/0001104659-24-077791.md","text":"https://secwatch.observer/filing/0001104659-24-077791.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000110465924077791/0001104659-24-077791-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000110465924077791/tm2418848d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:28:02.516273+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}